safety of glp 1 receptor agonists Comparative efficacy and GLP-1 for weight reduction: A model-based meta-analysis of placebo-controlled trials Overview of GLP-1 Receptor Agonist
Description
Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada
Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes
105 Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
In the context of metabolic health, three mechanisms stand out
Add electrolytes if needed to make increased water intake more palatable and to prevent electrolyte dilution
Comparison of Single and Combined Treatment With Exenatide and Metformin on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome
